ArticlePharmaceuticals (Basel, Switzerland)2024

Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists.

Mateusz Małkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.